Functional CT for assessment of early vascular physiology in liver tumors

Hepatobiliary and Pancreatic Diseases International

Volumn 7, Issue 5, 2008, Pages 497-502

  Jiang, Hui Jie ^a   Zhang, Zai Ren ^a   Shen, Bao Zhong ^a   Wan, Yong ^a   Guo, Hong ^a   Shu, Sheng Jie ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Animal model; Computed tomography; Hemodynamics; Liver tumors

Indexed keywords

IOHEXOL;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VOLUME; CAPILLARY PERMEABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; INOCULATION; LIVER BLOOD FLOW; LIVER BLOOD VESSEL; LIVER TUMOR; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONHUMAN; RABBIT; RATING SCALE; TUMOR GROWTH;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD VOLUME; CAPILLARY PERMEABILITY; CINEANGIOGRAPHY; CONTRAST MEDIA; HEMODYNAMICS; HEPATIC ARTERY; IOHEXOL; LIVER CIRCULATION; LIVER NEOPLASMS, EXPERIMENTAL; MODELS, CARDIOVASCULAR; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; RABBITS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 55049138973     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 2001;176:667-673.
2. Tsushima Y, Funabasama S, Aoki J, Sanada S, Endo K. Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol 2004;11:215-223.
3. Fuentes MA, Keith CJ, Griffiths M, Durbridge G, Miles KA. Hepatic haemodynamics: interrelationships between contrast enhancement and perfusion on CT and Doppler perfusion indices. Br J Radiol 2002;75:17-23.
4. Hoeffner EG, Case I, Jain R, Gujar SK, Shah GV, Deveikis JP, et al. Cerebral perfusion CT: technique and clinical applications. Radiology 2004;231:632-644.
5. Sanelli PC, Lev MH, Eastwood JD, Gonzalez RG, Lee TY. The effect of varying user-selected input parameters on quantitative values in CT perfusion maps. Acad Radiol 2004;11:1085-1092.
6. Dawson P. Functional imaging in CT. Eur J Radiol 2006; 60:331-340.
7. Koh TS, Tan CK, Cheong LH, Lim CC. Cerebral perfusion mapping using a robust and efficient method for deconvolution analysis of dynamic contrast-enhanced images. Neuroimage 2006;32:643-653.
8. Miles KA, Leggett DA, Kelley BB, Hayball MP, Sinnatamby R, Bunce I. In vivo assessment of neovascularization of liver metastases using perfusion CT. Br J Radiol 1998;71: 276-281.
9. Van Beers BE, Danse EM. Vascular lesions of the liver and gastrointestinal tract. Acta Gastroenterol Belg 2002;65:226-229.
10. Halavaara JT, Hamberg LM, Leong FS, Hunter GJ, Gazelle GS, Wolf GL. Functional CT with an experimental intravascular contrast agent in the assessment of liver vascular physiology. Acad Radiol 1996;3:946-952.
11. Livraghi T. Treatment of hepatocellular carcinoma by interventional methods. Eur Radiol 2001;11:2207-2219.
12. Seeff LB, Hoofnagle JH. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene 2006;25:3771-3777.
13. Waldman SA, Fortina P, Surrey S, Hyslop T, Kricka LJ, Graves DJ. Opportunities for near-infrared thermal ablation of colorectal metastases by guanylyl cyclase C-targeted gold nanoshells. Future Oncol 2006;2:705-716.
14. Miles KA. Functional computed tomography in oncology. Eur J Cancer 2002;38:2079-2084.
15. Purdie TG, Henderson E, Lee TY. Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. Phys Med Biol 2001;46:3161-3175.
16. Cuenod CA, Fournier L, Balvay D, Guinebretière JM. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom Imaging 2006;31:188-193.
17. Fournier LS, Cuenod CA, de Bazelaire C, Siauve N, Rosty C, Tran PL, et al. Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent. Eur Radiol 2004;14:2125-2133.
18. Kapanen MK, Halavaara JT, Hakkinen AM. Open four-compartment model in the measurement of liver perfusion. Acad Radiol 2005;12:1542-1550.
19. Tsushima Y, Koizumi J, Yokoyama H, Takeda A, Kusano S. Evaluation of portal pressure by splenic perfusion measurement using dynamic CT. AJR Am J Roentgenol 1998;170:153-155.
20. Blomley MJ, Coulden R, Dawson P, Kormano M, Donlan P, Bufkin C, et al. Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 1995;19:424-433.
21. Hashimoto K, Murakami T, Dono K, Hori M, Kim T, Kudo M, et al. Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging. Oncol Rep 2006;16:677-683.
22. Cuenod C, Leconte I, Siauve N, Resten A, Dromain C, Poulet B, et al. Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology 2001;218:556-561.
23. Stewart EE, Chen X, Hadway J, Lee TY. Correlation between hepatic tumor blood flow and glucose utilization in a rabbit liver tumor model. Radiology 2006;239:740-750.
24. Maruyama H, Matsutani S, Saisho H, Kamiyama N, Mine Y, Hirata T, et al. Sonographic shift of hypervascular liver tumor on blood pool harmonic images with definity: time-related changes of contrast-enhanced appearance in rabbit VX2 tumor under extra-low acoustic power. Eur J Radiol 2005;56:60-65.
25. Du WH, Yang WX, Xiong XQ, Wang X, Zhou Y, Wang H. Contrast-enhanced ultrasonographic imaging diagnosis on assessment of vascularity in liver metastatic lesions. World J Gastroenterol 2005;11:3610-3613.
26. Kan Z, Phongkitkarun S, Kobayashi S, Tang Y, Ellis LM, Lee TY, et al. Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model. Radiology 2005;237:151-158.
27. Matsubayashi R, Matsuo Y, Edakuni G, Satoh T, Tokunaga O, Kudo S. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 2000;217:841-848.
28. Ogawa M, Yamamoto H, Nagano H, Miyake Y, Sugita Y, Hata T, et al. Hepatic expression of ANG2 RNA in metastatic colorectal cancer. Hepatology 2004;39:528-539.
29. Ellika SK, Jain R, Patel SC, Scarpace L, Schultz LR, Rock JP, et al. Role of perfusion CT in glioma grading and comparison with conventional MR imaging features. AJNR Am J Neuroradiol 2007;28:1981-1987.
30. Aksoy FG, Lev MH. Dynamic contrast-enhanced brain perfusion imaging: technique and clinical applications. Semin Ultrasound CT MR 2000;21:462-477.
31. Miles KA. Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review. Eur J Radiol 1999;30:198-205.
32. Archer SG, Gray BN. Vascularization of small liver metastases. Br J Surg 1989;76:545-548.
33. Itai Y, Matsui O. Blood flow and liver imaging. Radiology 1997;202:306-314.